Abstract:Introduction Thyroid cancer is the most prevalent endocrine malignancy, with its global incidence increasing annually in recent years. Papillary carcinoma is the most common subtype, frequently accompanied by cervical lymph node metastasis early on. Central lymph node metastasis (CLNM) is particularly the common metastasis form in this subtype, and the presence of lymph node metastasis correlates strongly with tumor recurrence. However, effective preoperative assessment methods for CLNM in patients with papillary thyroid carcinoma (PTC) remain lacking. Methods Data from 400 patients diagnosed with PTC between January 1, 2018, and January 1, 2022, at the Shandong Provincial Hospital were retrospectively analyzed. This data included clinicopathological information of the patients, such as thyroid function, BRAF V600E mutation, whether complicated with Hashimoto’s thyroiditis, and the presence of capsular invasion. Univariate and multivariate logistic regression analyses were performed to assess the risk factors associated with cervical CLNM in patients with PTC. Subsequently, a clinical prediction model was constructed, and prognostic risk factors were identified based on univariate and multivariate Cox regression analyses. Results Univariate and multivariate analyses identified that age >45 years (P=0.014), body mass index ≥25 (P=0.008), tumor size ≥1 cm (P=0.001), capsular invasion (P=0.001), and the presence of BRAF V600E mutation (P<0.001) were significantly associated with an increased risk of CLNM. Integrating these factors into the nomogram revealed an area-under-the-curve of 0.791 (95% confidence interval 0.735–0.846) and 0.765 (95% confidence interval: 0.677–0.852) for the training and validation sets, respectively, indicating strong discriminative abilities. Subgroup analysis further confirmed that patients with papillary thyroid microcarcinoma and BRAF V600E mutations who underwent therapeutic central compartment neck dissection had significantly better 3-year disease-free survival than those who had prophylactic central compartment neck dissection (P<0.001). Conclusion The study revealed that age >45 years, body mass index ≥25, tumor size ≥1 cm, BRAF V600E mutation, and capsular invasion are the related risk factors for CLNM in patients with PTC. For patients with clinically nodal-negative (cN0) papillary thyroid microcarcinoma, accurately identifying the BRAF V600E mutation is essential for guiding the central lymph node dissection approach and subsequent treatments.

Predictors of Bilateral Central Neck Lymph Node Dissection in Unilateral Papillary Thyroid Carcinoma.

The Incidence And Predictive Factors For Central Lymph Node Metastasis In Unilateral Papillary Thyroid Carcinoma

Evaluation of Clinical Risk Factors for Predicting Insidious Right Central and Posterior Right Recurrent Laryngeal Nerve Lymph Node Metastasis in Papillary Thyroid Microcarcinoma Patients (cn0): Experience of a Single Center.

Prediction Mode of More Than 5 Central Lymph Nodes Metastases in Clinically Node-Negative Ipsilateral Papillary Thyroid Carcinoma with Tumor Size 1 to 4 Cm

Prediction of Ipsilateral and Contralateral Central Lymph Node Metastasis in Unilateral Papillary Thyroid Carcinoma: a Retrospective Study.

[Related Factors of Central Lymph Node Metastasis in Papillary Thyroid Carcinoma].

Predictive Factors Of Contralateral Paratracheal Lymph Node Metastasis In Unilateral Papillary Thyroid Carcinoma.

Predictors for Central Lymph Node Metastases in CN0 Papillary Thyroid Microcarcinoma (mptc): A Retrospective Analysis of 1304 Cases.

Risk Factors of Central Lymph Node Metastasis and Significance of Prophylactic Central Lymph Node Dissection for Cn0 Papillary Thyroid Carcinoma

Risk Factors of Central Lymph Node Metastasis in Cn0 Papillary Thyroid Carcinoma: A Study of 529 Patients

Predictive factors for lymph node metastasis in papillary thyroid cancer patients undergoing neck dissection: insights from a large cohort study

Conventional Ultrasound, Immunohistochemical Factors and BRAFV600E Mutation in Predicting Central Cervical Lymph Node Metastasis of Papillary Thyroid Carcinoma.

Pretracheal Lymph Node Subdivision in Predicting Contralateral Central Lymph Node Metastasis for Unilateral Papillary Thyroid Carcinoma: Preliminary Results

Risk factors of cervical central lymph node metastasis in stage T1a unifocal papillary thyroid carcinoma

Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study

A Prediction Model for Contralateral Central Neck Lymph Node Metastases in Unilateral Papillary Thyroid Cancer

The Clinical Predictors Of Metastasis To Lymph Nodes Posterior To Right Recurrent Laryngeal Nerve In Cno Papillary Thyroid Cancer

Predictive Factors of Central-Compartment Lymph Node Metastasis for Clinical N0 Papillary Thyroid Carcinoma With Strap Muscle Invasion.

The Oncologic Outcomes of Bilateral Central Lymph Node Dissection in Unilobar Papillary Thyroid Cancer and Its Risks: A Prospective Cohort Study

Predictive factors for non-small-volume central lymph node metastases (more than 5 or ≥ 2 mm) in clinically node-negative papillary thyroid carcinoma.

Cervical Lymph Node Metastasis Differences in Patients with Unilateral or Bilateral Papillary Thyroid Microcarcinoma: A Multi-Center Analysis